Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
Holding CNTA?
Track your performance easily

Centessa Pharmaceuticals (CNTA) Stock Investors

111 Followers
Based on 766,063 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CNTA
On average, investors allocate 0.00% of their portfolios to CNTA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,063 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CNTA

26.6%
Last 7
Days
50.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CNTA, out of 766,063 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CNTA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,653 investors who made their portfolios public
The table shows changes in CNTA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CNTA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
XPeng, Inc. ADR
5.57%
-0.86%
-1.05%
13.95B
Consumer Cyclical
Carnival
6.49%
+1.32%
+8.73%
30.17B
Consumer Cyclical
Riot Platforms
5.31%
+0.17%
+1.75%
4.26B
Financial
DraftKings
5.44%
+1.26%
-0.14%
35.26B
Consumer Cyclical
Airbnb
4.35%
+0.76%
-0.37%
86.37B
Consumer Cyclical
Viking Therapeutics
4.93%
+0.69%
+5.26%
7.63B
Healthcare
Block
4.24%
+0.77%
+1.79%
45.90B
Technology
UiPath
3.61%
-1.35%
-2.97%
7.24B
Technology
Trade Desk
4.92%
+0.70%
+2.56%
61.68B
Technology
Devon Energy
4.69%
+1.34%
+1.80%
25.53B
Energy
Based on the activity of 766,063 active portfolios
Open your Smart Portfolio

CNTA Investor Analysis

CNTA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.5%
of CNTA holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
CNTA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.5%
of CNTA holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
CNTA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of CNTA holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of CNTA stock investors
See who invests in CNTA according to age group and performance.

FAQ

How many retail Investors hold CNTA?
<0.1% of TipRanks' retail investors hold CNTA in their portfolios.
    What is CNTA Investor Sentiment?
    CNTA’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CNTA in the last 7 days?
      ▲ 26.6% of TipRanks' retail investors changed their holding of CNTA in the last 7 days.
        What percentage of retail investors changed their holding of CNTA in the last 30 days?
        ▲ 50.8% of TipRanks' retail investors changed their holding of CNTA in the last 30 days.
          What is the average age of retail investors who hold CNTA?
          The average age of CNTA Holders is over 55.
            What other stocks have CNTA investors also bought?
            CNTA Investors also bought XPEV, CCL, RIOT, DKNG, ABNB, VKTX, SQ, PATH, TTD, DVN.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AAgilent
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis